About
Georgia Gayle joined the Economic Progress Institute Board in October 2026.
Georgia Gayle is Director, Head of U.S. Promotional Review & Operations at Alexion, AstraZeneca Rare Disease, where she leads governance, operational strategy, compliance, systems, and transformation across U.S. promotional review. With more than a decade of experience across biopharma and healthcare, she has built cross-functional operating models, advised senior leaders, strengthened governance and risk frameworks, managed strategic partnerships, and led complex transformations designed to improve accountability, quality, and execution.
Her career has been rooted in rare disease, where patients, caregivers, and healthcare professionals often navigate serious and highly complex conditions. That experience has reinforced for Georgia the importance of clear, responsible communication and strong operating systems that help organizations serve people with greater consistency, accountability, and care.
Georgia is also a co-founder of the Edna May Morris Foundation, a family-led charitable initiative focused on expanding educational opportunity and supporting children and families through scholarships, school resources, and community programs. She is an industry speaker and moderator on governance, operational excellence, responsible innovation, and cross-functional collaboration, and co-author of the white paper "Human-AI Collaboration in MLR: Augmentation vs. Automation."
A Barrington, Rhode Island resident and mother of two, Georgia is deeply invested in the economic security, opportunity, and well-being of Rhode Island families and communities. She holds an Executive MBA from Baruch College’s Zicklin School of Business, BBAs in International Business and Marketing from Berkeley College, and completed the U.S. Healthcare Compliance Certificate Program PLUS, with a specialization in the Foreign Corrupt Practices Act (FCPA), at Seton Hall University School of Law.
Back to all board members